Quest Diagnostics, Inc. (DGX)

Schlusskurs vom Vortag:

$137.55

Offen:

$137.42

24-Stunden-Volumen:

17,072

Marktkapitalisierung:

$15.28B

Einnahmen:

$9.29B

Nettoeinkommen (Verlust:

$846.00M

KGV:

20.54

EPS:

6.66

Netto-Cashflow:

$947.00M

1W Leistung:

+1.02%

1M Leistung:

+3.41%

6M Leistung:

+4.17%

1J Leistung:

-0.95%

1-Tages-Spanne:

$136.42

$137.42

52-Wochen-Spanne:

$119.59

$145.58

Quest Diagnostics, Inc. Stock (DGX) Company Profile

Firmenname

Quest Diagnostics, Inc.

Sektor

Healthcare (1193)

Branche

Diagnostics & Research (66)

Telefon

973 520 2700

Adresse

500 Plaza Drive, Secaucus

Mitarbeiter

45,000

Twitter

@QuestDX

Nächster Verdiensttermin

2024-05-16

Neueste SEC-Einreichungen

DGX's Discussions on Twitter

Quest Diagnostics, Inc. Stock (DGX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-02-07	Hochstufung	Jefferies	Hold → Buy
2024-01-03	Eingeleitet	Barclays	Equal Weight
2023-12-12	Hochstufung	BofA Securities	Neutral → Buy
2023-06-29	Eingeleitet	Piper Sandler	Neutral
2023-05-02	Herabstufung	BofA Securities	Buy → Neutral
2023-04-03	Hochstufung	Citigroup	Sell → Neutral
2023-01-23	Eingeleitet	Evercore ISI	In-line
2022-11-17	Herabstufung	Citigroup	Neutral → Sell
2022-08-22	Fortgesetzt	Morgan Stanley	Equal-Weight
2022-04-04	Herabstufung	Citigroup	Buy → Neutral
2022-02-23	Herabstufung	UBS	Buy → Neutral
2022-02-02	Herabstufung	Jefferies	Buy → Hold
2022-01-28	Herabstufung	Deutsche Bank	Buy → Hold
2021-05-04	Hochstufung	UBS	Neutral → Buy
2021-03-12	Herabstufung	Robert W. Baird	Outperform → Neutral
2020-10-21	Hochstufung	Argus	Hold → Buy
2020-07-29	Hochstufung	KeyBanc Capital Markets	Sector Weight → Overweight
2020-07-14	Hochstufung	BofA Securities	Neutral → Buy
2020-06-09	Hochstufung	Wells Fargo	Underweight → Equal Weight
2020-06-02	Hochstufung	Deutsche Bank	Hold → Buy
2020-04-28	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2020-04-27	Hochstufung	Citigroup	Neutral → Buy
2020-04-27	Hochstufung	Wolfe Research	Underperform → Peer Perform
2020-03-27	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2020-01-08	Eingeleitet	Wells Fargo	Underweight
2020-01-07	Herabstufung	Barclays	Overweight → Equal Weight
2019-12-19	Hochstufung	BofA/Merrill	Underperform → Neutral
2019-07-15	Herabstufung	Goldman	Neutral → Sell
2019-04-02	Hochstufung	Jefferies	Hold → Buy
2019-03-18	Fortgesetzt	Credit Suisse	Neutral
2019-01-31	Herabstufung	Argus	Buy → Hold
2019-01-17	Eingeleitet	UBS	Neutral
2019-01-03	Herabstufung	BofA/Merrill	Neutral → Underperform
2018-12-03	Herabstufung	BofA/Merrill	Buy → Neutral
2018-11-30	Herabstufung	Goldman	Buy → Neutral

Alle ansehen

Quest Diagnostics, Inc. Aktie (DGX) Neueste Nachrichten

The Analyst Landscape: 5 Takes On Quest Diagnostics

Benzinga

Quest Diagnostics Says Sales In Q1 Increased For The First Time Since The Height Of Pandemic

Benzinga

Quest Diagnostics (DGX) Q1 Earnings Top Estimates, Margins Down

Zacks Investment Research

Quest Diagnostics (DGX) Beats Q1 Earnings and Revenue Estimates

Zacks Investment Research

Unlocking Q1 Potential of Quest Diagnostics (DGX): Exploring Wall Street Estimates for Key Metrics

Zacks Investment Research

US Stocks Set To Open Fresh Week Higher On Big Tech Earnings Hopes: Analyst Warns Any Letdown Could Push Market 'Deeper Into Oversold Territory'

Benzinga

Finanzdaten der Quest Diagnostics, Inc.-Aktie (DGX)

Quest Diagnostics, Inc. (DGX) Umsatz 2024

Quest Diagnostics, Inc. (DGX) Nettogewinn 2024

Quest Diagnostics, Inc. (DGX) Free Cashflow 2024

Quest Diagnostics, Inc. (DGX) Gewinn je Aktie 2024

Quest Diagnostics, Inc.-Aktie (DGX) Insiderhandel